Evidence map›Paper›PMID 27138790›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2016

Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β.

Shakir M Saud, Weidong Li, Zane Gray, Matthias S Matter, Nancy H Colburn, Matthew R Young, Young S Kim

Open access · greenAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Biological Functions of Diallyl Disulfide, a Garlic-Derived Natural Organic Sulfur Compound.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Shakir M SaudNutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland. Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
Weidong LiLaboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, Maryland. Department of Infectious Disease, Guang'anmen Hospital, Beijing, China.
Zane GrayLaboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
Matthias S MatterInstitute of Pathology, University Hospital of Basel, Basel, Switzerland.
Nancy H ColburnLaboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
Matthew R YoungLaboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, Maryland. Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland.
Young S KimNutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland. yk47s@nih.gov.
Frederick National Laboratory for Cancer Research · USNational Cancer Institute · USUniversity Hospital of Basel · CH

Funding

Identification of Biomarkers for Response to Chemoprevention of Colon CancerZIABC011159 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI COLBURN, NANCY H. · 2009 to 2013
$1.3M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC011159
6 · The paper itself

Abstract

There is a strong belief that garlic has medicinal properties and may even reduce the risk of developing certain cancers including those of the gastrointestinal tract. The chemopreventive effects of garlic may be attributed to the anti-inflammatory properties of the sulfur-containing constituents of garlic, which includes diallyl disulfide (DADS). Here, we demonstrate that DADS prevented colorectal tumorigenesis in a mouse model of colitis-induced colorectal cancer. Supplementation with 85 ppm of DADS (60 mg daily human equivalent dose) in the diet of FVB/N mice treated with chemical carcinogen azoxymethane (AOM) and colonic irritant dextran sodium sulfate (DSS) resulted in the reduction in tumor incidence, tumor number, and tumor burden by 21.54%, 47.3%, and 66.4%, respectively. Further analysis revealed that mice fed the DADS-supplemented diet resolved the initial DSS-induced inflammation faster than those on the control diet, preventing prolonged inflammation and cellular transformation. Subsequent mechanistic studies in vitro suggest that DADS chemopreventive effects are mediated through NF-κB signaling. When SW480 colorectal cancer cells were treated with DADS, NF-κB nuclear localization and activity were diminished. Interestingly, NF-κB suppression was found to be dependent on DADS inhibition of GSK-3β, a positive regulator of NF-κB. Inhibition of GSK-3β and loss of nuclear NF-κB activity were also observed in vivo in AOM/DSS-treated mice fed a diet supplemented with 85 ppm DADS. Our results indicate that DADS can prevent tumorigenesis by suppressing inflammation, a process largely involving GSK-3β inhibition and consequential reduction in NF-κB nuclear localization. Cancer Prev Res; 9(7); 607-15. ©2016 AACR.

Indexed as

Allyl CompoundsAnimalsAntineoplastic Agents, PhytogenicCarcinogenesisCell Line, TumorCell ProliferationColitisColorectal NeoplasmsDisulfidesGarlicGlycogen Synthase Kinase 3 betaHumansInflammationMiceNF-kappa BPlant ExtractsAllyl CompoundsAntineoplastic Agents, Phytogenicdiallyl disulfideDisulfidesGlycogen Synthase Kinase 3 betaNF-kappa BPlant Extracts

Identifiers

PMID27138790
PMCPMC4930730
OpenAlexW2346880338

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.